The Health Data ‘Dream State’
By: [email protected], Content Manager, Swoop
How condition-specific audience segments can lift your brand beyond traditional targeting.
[email protected], SVP of sales at Swoop, explains how pharma brands can leverage condition-specific patient segments to connect with more relevant consumer audiences online. Carr explains why real-world health data (RWD) in conjunction with artificial intelligence (AI) is the building block of custom audiences — and how custom segments provide a better way than traditional targeting methodologies for brands to drive script lift.
About the Author
[email protected]
Content Manager
| |
|
Emilie has nearly a decade of experience in marketing, writing, research and strategy for the pharmaceutical industry. She has contributed to top pharmaceutical publications including American Pharmaceutical Review, European Pharmaceutical Review, Pharmaceutical Manufacturing, Manufacturing Chemist, Pharmaceutical Outsourcing, Specialty Chemicals, and Contract Pharma. Prior to joining Swoop/IPM.ai, Emilie served as Strategic Content Manager and Managing Editor for Pharma’s Almanac where she lent her voice to some of the industry’s top players including GSK, MilliporeSigma and ThermoFisher Scientific.
|
Swoop
Transforming Omnichannel
Swoop is a leading provider of AI-driven, precision healthcare omnichannel solutions dedicated to protecting consumer privacy and improving patient outcomes. By prioritizing privacy and compliance, Swoop delivers industry-leading audience segments, 100% MLR-approved conversational AI agents, and now a leading opted-in patient social network in the U.S. through its acquisition of MyHealthTeam. Swoop’s solutions drive meaningful patient and provider engagement, optimal conversion, and measurable increases in Rx lift across the patients’ health journey.
